HPM to Host Complimentary Webinar on US Regulatory Strategy for MedTech Startups

Hyman, Phelps & McNamara, P.C. (HPM) is hosting a complimentary webinar, titled “From Prototype to Approval: US Regulatory Strategy for MedTech Startups.” The webinar is scheduled for March 25, 2026 (11:00am to 12:00pm ET).

Bringing a medical device from prototype to market requires more than innovation—it demands a smart, proactive regulatory strategy, one that is aligned with business objectives. This webinar is designed for early-stage MedTech founders and startup teams who want to navigate US regulatory requirements efficiently and avoid costly delays. We’ll break down key marketing authorization pathways, discuss strategies for interacting with FDA, and explain how regulatory decisions impact product design, clinical strategy, timelines, and funding. Attendees will gain practical guidance on device classification, pre-submissions, clinical evidence planning, and common pitfalls that can slow approval. Whether you’re refining your prototype or preparing for submission, this session will help you build a regulatory roadmap that accelerates approval and strengthens investor confidence.

The webinar will feature HPM attorney Jennifer Newberger and Principal Medical Device Regulatory Expert, Lisa Baumhardt.   You can register for the complimentary webinar here.   After registering, you will receive a confirmation email containing information about joining the webinar.